Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Howard, Katzenstein"'
Autor:
Bradford S. Hoppe, Raymond B. Mailhot Vega, Nancy P. Mendenhall, Eric S. Sandler, William B. Slayton, Howard Katzenstein, Michael J. Joyce, Zuofeng Li, Stella Flampouri
Publikováno v:
International Journal of Particle Therapy, Vol 6, Iss 4, Pp 1-6 (2020)
Background: Local relapse is a predominant form of recurrence among pediatric patients with Hodgkin lymphoma (PHL). Although PHL radiotherapy doses have been approximately 20 Gy, adults with Hodgkin lymphoma receiving 30 to 36 Gy experience fewer in-
Externí odkaz:
https://doaj.org/article/e8df6e5ee94843579f76659bc71100d5
Autor:
Pavel Sumazin, Tricia L. Peters, Stephen F. Sarabia, Hyunjae R. Kim, Martin Urbicain, Emporia Faith Hollingsworth, Karla R. Alvarez, Cintia R. Perez, Alice Pozza, Mohammad Javad Najaf Panah, Jessica L. Epps, Kathy Scorsone, Barry Zorman, Howard Katzenstein, Allison F. O’Neill, Rebecka Meyers, Greg Tiao, Jim Geller, Sarangarajan Ranganathan, Arun A. Rangaswami, Sarah E. Woodfield, John A. Goss, Sanjeev A. Vasudevan, Andras Heczey, Angshumoy Roy, Kevin E. Fisher, Rita Alaggio, Kalyani R. Patel, Milton J. Finegold, Dolores H. López-Terrada
Publikováno v:
Journal of hepatology. 77(4)
Hepatoblastoma (HB) and hepatocellular carcinoma (HCC) are the predominant liver cancers in children, though their respective treatment options and associated outcomes differ dramatically. Risk stratification using a combination of clinical, histolog
Autor:
Frank Liu, Halley Costantino, Chiemeka Ike, Shaloo Gupta, Abhijeet Bhanegaonkar, Sheena Thakkar, Geeta Devgan, Howard Katzenstein, Shilpa Gupta
Publikováno v:
Journal of Clinical Oncology. 40:4595-4595
4595 Background: The treatment (tx) landscape for la/mUC has evolved with the use of immunotherapy (IO) for platinum-refractory la/mUC as well as first-line (1L) maintenance therapy (1LM). This cross-sectional survey explored practice patterns for 1L
Autor:
Shilpa Gupta, Cathy Su, Abhijeet Bhanegaonkar, Shaloo Gupta, Sheena Thakkar, deMauri S Mackie, Geeta Devgan, Howard Katzenstein, Frank Liu
Publikováno v:
Journal of Clinical Oncology. 40:456-456
456 Background: The treatment landscape for la/mUC is evolving. Data on current real-world treatment trends in la/mUC are limited. This study assessed US physician treatment decision-making and prescribing patterns using qualitative interviews (QIs).
Autor:
Petros Grivas, Pedro C. Barata, Helen Moon, Thomas E. Hutson, Shilpa Gupta, Cora N. Sternberg, A. Simon Pickard, Vaidehi Dave, Natalia Han, Alicia C. Shillington, Geeta Devgan, Ruth Kim, Sheena Thakkar, Howard Katzenstein, Abhijeet Bhanegaonkar, Frank Liu, Guru P. Sonpavde
Publikováno v:
Journal of Clinical Oncology. 40:TPS578-TPS578
TPS578 Background: The randomized phase 3 JAVELIN Bladder 100 trial demonstrated overall and progression-free survival (OS and PFS) benefit with Ave 1LM for la/mUC not progressed with platinum-containing chemotherapy (PCT). PATRIOT II aims to underst
Autor:
Howard Katzenstein
Publikováno v:
Journal of Clinical Oncology. 38:3076-3076
Publikováno v:
The American Journal of Human Genetics. 72(4):812-822
The presence of four lysosomal storage diseases (LSDs) at increased frequency in the Ashkenazi Jewish population has suggested to many the operation of natural selection (carrier advantage) as the driving force. We compare LSDs and nonlysosomal stora
Autor:
Heidi V, Russell, Susan G, Groshen, Tasnim, Ara, Yves A, DeClerck, Randy, Hawkins, Hollie A, Jackson, Heike E, Daldrup-Link, Araz, Marachelian, Andrej, Skerjanec, Julie R, Park, Howard, Katzenstein, Katherine K, Matthay, Susan M, Blaney, Judith G, Villablanca
Publikováno v:
Pediatric bloodcancer. 57(2)
Zoledronic acid, a bisphosphonate, delays progression of bone metastases in adult malignancies. Bone is a common metastatic site of advanced neuroblastoma. We previously reported efficacy of zoledronic acid in a murine model of neuroblastoma bone inv
Publikováno v:
Pediatric bloodcancer. 53(3)
Second malignancies occur in 2-3% of survivors of pediatric osteosarcoma; treatment-related hematologic and solid malignancies have both been described. We present two cases of patients with pulmonary nodules that developed more than 2 years after tr
Autor:
Josef Ekstein, Howard Katzenstein
Publisher Summary This chapter describes the community characteristics and dynamics, which are the context for the Dor Yeshorim program, along with the mechanics of the program. The 17-year history, its findings and accomplishments are summarized wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9051d35a318836177b081686956f546e
https://doi.org/10.1016/s0065-2660(01)44087-9
https://doi.org/10.1016/s0065-2660(01)44087-9